Press Releases GeoVax Labs, Inc.

Equities

GOVX

US3736786068

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-20 pm EDT			5-day change	1st Jan Change
1.63 ^USD	-4.12%		-1.21%	-69.90%

May. 14	Transcript : GeoVax Labs, Inc., Q1 2024 Earnings Call, May 14, 2024
Mar. 28	GeoVax Labs, Inc. to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market	May. 17	AQ
GeoVax Labs : Reports First Quarter 2024 Financial Results and Provides Business Update - Form 8-K	May. 15	PU
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update	May. 14	AQ
GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024	May. 07	AQ
GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine	Apr. 04	AQ
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress	Mar. 28	AQ
GeoVax to Present at the 36th Annual Roth Conference	Mar. 12	AQ
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System	Mar. 06	AQ
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update	Feb. 29	AQ
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024	Feb. 22	AQ
GeoVax to Present at the 2024 BIO CEO & Investor Conference	Feb. 19	AQ
GeoVax Announces Multiple Patent Issuances and Allowances	Feb. 13	AQ
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster	Feb. 06	AQ
GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement	Jan. 29	AQ
GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology	Jan. 08	AQ
GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients	Jan. 04	AQ
GeoVax Announces Issuance of Malaria Vaccine Patent	Jan. 03	AQ
GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024	Dec. 27	AQ
GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox	Dec. 19	AQ
GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress	Nov. 30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases GeoVax Labs, Inc.

Equities

GOVX

US3736786068

Press Releases

Filters